Estuardo Aguilar-Cordova

Insider Reports History

Entity
Individual
Location
Candel Therapeutics, Inc., 117 Kendrick St Suite 450, Needham, MA
Signature
Estuardo Aguilar-Cordova
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Estuardo Aguilar-Cordova:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Candel Therapeutics, Inc. 10%+ Owner CADL 2.07M $10.2M $4.92 Nov 6, 2024 By Estuardo Aguilar-Cordova 2020 Irrevocable Trust
Candel Therapeutics, Inc. 10%+ Owner CADL 2.01M $9.9M $4.92 Nov 6, 2024 Laura K. Aguilar 2020 Irrevocable Trust
Candel Therapeutics, Inc. 10%+ Owner CADL 874K $4.3M $4.92 Nov 8, 2024 Direct
Candel Therapeutics, Inc. 10%+ Owner CADL 831K $4.09M $4.92 Nov 8, 2024 By LKA 2022 Revocable Trust

Insider Reports Filed by Estuardo Aguilar-Cordova

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CADL Candel Therapeutics, Inc. Nov 6, 2024 6 -$232K 4 Nov 8, 2024 10%+ Owner
CADL Candel Therapeutics, Inc. Oct 30, 2024 6 -$223K 4 Nov 1, 2024 10%+ Owner
CADL Candel Therapeutics, Inc. Oct 24, 2024 4 -$172K 4 Oct 28, 2024 10%+ Owner
CADL Candel Therapeutics, Inc. Oct 11, 2024 3 -$244K 4 Oct 15, 2024 10%+ Owner
CADL Candel Therapeutics, Inc. Oct 1, 2024 3 -$156K 4 Oct 3, 2024 10%+ Owner
CADL Candel Therapeutics, Inc. Jun 28, 2023 1 $0 4 Jun 29, 2023 Director
CADL Candel Therapeutics, Inc. Oct 13, 2022 1 $0 4 Oct 17, 2022 Director
CADL Candel Therapeutics, Inc. May 6, 2022 5 -$3 4 May 10, 2022 Director, 10%+ Owner
CADL Candel Therapeutics, Inc. Jul 29, 2021 2 $0 4 Aug 2, 2021 Chief Scientific Officer, Director
CADL Candel Therapeutics, Inc. Jul 26, 2021 0 $0 3 Jul 26, 2021 Chief Scientific Officer, Director